Disialoganglioside GD2, human Antigen

Cat.# 8G16-8h

This data sheet is provided for information only. After adding the product to the cart by clicking the button below you will see if there is a volume discount available.

Sign up or login to see prices and to request offers

Price:
-- / mg
Login for price
* All prices excluding VAT
Request an offer Sample Request

Questions? Schedule online meeting

Gangliosides
  • Cat.#

    8G16-8h

  • Source:

    Human brain tissue. Blood sample from the tissue donors was tested and found negative for HBsAg, HIV-1 and HIV-2 antibodies, HCV, and syphilis.

  • Applications:

    Prepared from human GD1b ganglioside by enzymatic disintegration of the terminal galactose. Known as a specific cancer ganglioside. The antibodies to the GD2 inhibit cell attachment to various extracellular matrix proteins (collagen, vitronectin, laminin, fibronectin).

  • Analysis:

    Purity more than 98 % by HPTLC. MW 1649

  • Presentation:

    Lyophilized from water solution.

  • Storage:

    Before and after reconstitution at -20 °C (-15 … -30 °C allowed)

  • Material safety note:

    This product is sold for research use only. Standard Laboratory Practices should be followed when handling this material.

×

Bulk Price Quotation

You can request quotations by filling in the desired amount and your information. Please note that if you register or login you can see the prices immediately without waiting for quotes. You can also request a sample here.

Disialoganglioside GD2, human Antigen

(Catalogue number and MAb: 8G16-8h-)

Information

×

Sample Request

Disialoganglioside GD2, human Antigen

(Catalogue number and MAb: 8G16-8h-)

Evaluation samples available. You can save up to 50%*

Information

*The usual shipping and handling costs will still apply. The sample opportunity is a one-time evaluation possibility and you can get more details by contacting HyTest customer service.
×

Schedule Online Meeting

Please fill in the form below and we will contact you by email and schedule a meeting.

Information

Sign up to our newsletter

And be informed about new products and scientific findings

Thank you for your subscription!